Tolnaftate 0.01 MG/MG Powder Spray — RxCUI 705934
RxNorm drug concept · Semantic clinical drug
RxCUI 705934
Semantic clinical drug · SCD
● Current RxNorm concept 42 FDA products
44 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI705934
Official nameTolnaftate 0.01 MG/MG Powder Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astolnaftate 1 % Powder Spray
FDA products mapped42
Package NDCs mapped44
Reported Medicaid activity (SDUD)457 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Tolnaftate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on what you're treating. For athlete's foot and ringworm, plan on using it daily for about 4 weeks. For jock itch, 2 weeks is the usual course. Some products mention you...
- How long does it take for tolnaftate to work?
- Tolnaftate is not effective for treating infections on the scalp or on the nails themselves — most products say so right on the label. Some liquid and patch products are designed t...
- Stop applying the product and let your doctor know. A little initial sensitivity can happen, but worsening irritation is a sign that you should get it checked out. Don't push throu...
🕸️ Concept Web — How Tolnaftate 0.01 MG/MG Powder Spray Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Tolnaftate 0.01 MG/MG Powder Spray
RxCUI 705934 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Tolnaftate
10637IN
-
Tolnaftate
-
Brand names 3
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Hongo Killer Antifungal
1101779BN -
Lamisil Defense
692846BN -
Tinactin
220322BN
-
Hongo Killer Antifungal
-
Dose forms 10
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Tolnaftate Powder Spray
374158SCDF -
Tolnaftate Topical Product
1157650SCDG -
Tolnaftate Powder Spray [Hongo Killer Antifungal]
1101786SBDF -
Tolnaftate Powder Spray [Lamisil Defense]
996161SBDF -
Tolnaftate Powder Spray [Tinactin]
705935SBDF -
Hongo Killer Antifungal Topical Product
1171277SBDG -
Lamisil Defense Topical Product
1174988SBDG -
Tinactin Topical Product
1179077SBDG - +2 more in this family
-
Tolnaftate Powder Spray
-
Clinical & branded drugs 7
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Tolnaftate 0.01 MG/MG
340019SCDC -
Tolnaftate 0.01 MG/MG Powder Spray [Hongo Killer Antifungal]
1101787SBD -
Tolnaftate 0.01 MG/MG Powder Spray [Lamisil Defense]
1037248SBD -
Tolnaftate 0.01 MG/MG Powder Spray [Tinactin]
705936SBD -
Tolnaftate 0.01 MG/MG [Hongo Killer Antifungal]
1101783SBDC -
Tolnaftate 0.01 MG/MG [Lamisil Defense]
692847SBDC -
Tolnaftate 0.01 MG/MG [Tinactin]
570248SBDC
-
Tolnaftate 0.01 MG/MG
Showing up to 8 concepts per family — 19 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Tolnaftate 0.01 MG/MG
SCDC · 340019 -
Tolnaftate Powder Spray
SCDF · 374158 -
Tolnaftate Topical Product
SCDG · 1157650
Brand-Name Concepts
-
Tolnaftate 0.01 MG/MG Powder Spray [Hongo Killer Antifungal]
SBD · 1101787 -
Tolnaftate 0.01 MG/MG Powder Spray [Tinactin]
SBD · 705936 -
Tolnaftate 0.01 MG/MG Powder Spray [Lamisil Defense]
SBD · 1037248 -
Tolnaftate 0.01 MG/MG [Hongo Killer Antifungal]
SBDC · 1101783 -
Tolnaftate 0.01 MG/MG [Lamisil Defense]
SBDC · 692847 -
Tolnaftate 0.01 MG/MG [Tinactin]
SBDC · 570248 -
Tolnaftate Powder Spray [Hongo Killer Antifungal]
SBDF · 1101786 -
Tolnaftate Powder Spray [Lamisil Defense]
SBDF · 996161 -
Tolnaftate Powder Spray [Tinactin]
SBDF · 705935 -
Hongo Killer Antifungal Topical Product
SBDG · 1171277
📦 FDA Products & Package NDCs
42 products · 44 package NDCs
44 package NDCs map to RxCUI 705934 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00363-1746-00 | 130 g in 1 CAN (0363-1746-00) | Tolnaftate | Walgreens Company | 2021-10-20 |
| 10157-4645-01 | 113 g in 1 CAN (10157-4645-1) | Blistex Odor-Eaters Powder | Blistex Inc | 2013-12-09 |
| 10157-4645-02 | 151 g in 1 CAN (10157-4645-2) | Blistex Odor-Eaters Powder | Blistex Inc | 2021-11-15 |
| 11523-0010-01 | 160 g in 1 CAN (11523-0010-1) | Lotrimin Daily Prevention Deo | Bayer HealthCare LLC. | 2020-02-14 |
| 11523-0010-02 | 133 g in 1 CAN (11523-0010-2) | Lotrimin Daily Prevention Deo | Bayer HealthCare LLC. | 2020-02-14 |
| 11523-0136-01 | 160 g in 1 CAN (11523-0136-1) | Lotrimin Daily Prevent Deodorant | Bayer HealthCare LLC. | 2024-03-01 |
| 11523-0137-01 | 133 g in 1 CAN (11523-0137-1) | Tinactin Deodorant | Bayer HealthCare LLC. | 2024-03-01 |
| 11523-0138-01 | 133 g in 1 CAN (11523-0138-1) | Tinactin Jock Itch | Bayer HealthCare LLC | 2024-03-01 |
| 11523-0139-01 | 133 g in 1 CAN (11523-0139-1) | Tinactin | Bayer HealthCare LLC. | 2023-11-29 |
| 11523-4162-01 | 133 g in 1 CAN (11523-4162-1) | Tinactin Antifungal | Bayer HealthCare LLC. | 2014-02-28 |
| 11822-0782-04 | 130 g in 1 CAN (11822-0782-4) | Tolnaftate | Rite Aid Corporation | 2021-03-15 |
| 16864-0110-01 | 57 g in 1 CAN (16864-110-01) | Kerasal Athletes Foot powder | Advantice Health, LLC | 2022-02-28 |
| 21130-0215-00 | 130 g in 1 CAN (21130-215-00) | Tolnafate | Better Living Brands LLC | 2021-09-27 |
| 23667-0806-01 | 130 g in 1 CAN (23667-806-01) | GoodSense Powder Jock Itch Antifungal | Formulated Solutions, LLC | 2017-01-20 |
| 23667-0807-01 | 130 g in 1 CAN (23667-807-01) | Walgreens Maximum Strength Jock Itch Antifungal | Formulated Solutions, LLC | 2017-01-20 |
| 23667-0809-01 | 130 g in 1 CAN (23667-809-01) | Meijer Maximum Strength Jock Itch Relief Antifungal | Formulated Solutions, LLC | 2017-01-21 |
| 23667-0810-01 | 130 g in 1 CAN (23667-810-01) | Meijer Maximum Strength Anthletes foot Antifungal | Formulated Solutions, LLC | 2017-01-21 |
| 23667-0814-01 | 130 g in 1 CAN (23667-814-01) | Signature Athletes Foot Antifungal | Formulated Solutions, LLC | 2017-01-21 |
| 23667-0818-01 | 130 g in 1 CAN (23667-818-01) | Walgreens Medicated Antifungal Athletes Foot | Formulated Solutions, LLC | 2017-01-23 |
| 30142-0841-01 | 130 g in 1 CAN (30142-841-01) | Tolnaftate | Kroger Co. | 2022-03-11 |
| 36800-0023-04 | 113 g in 1 CAN (36800-023-04) | Tolnaftate | Topco Associates LLC | 2012-01-05 |
| 36800-0876-46 | 130 g in 1 CAN (36800-876-46) | Tolnafate | Topco Associates LLC | 2017-05-22 |
| 36800-0877-46 | 130 g in 1 CAN (36800-877-46) | Tolnaftate | Topco Associates LLC | 2017-10-31 |
| 37808-0514-40 | 113 g in 1 CAN (37808-514-40) | Tolnaftate | HEB | 2012-01-05 |
| 37808-0530-46 | 130 g in 1 CAN (37808-530-46) | Tolnafate | HEB | 2017-12-22 |
| 41520-0086-04 | 113 g in 1 CAN (41520-086-04) | Tolnaftate | Foodhold USA | 2017-12-19 |
| 54312-0230-01 | 130 g in 1 BOTTLE, SPRAY (54312-230-01) | Derman Antifungal | Compania Internacional de Comercio, S.A.P.I. de C.V. | 2025-11-13 |
| 55301-0874-01 | 130 g in 1 CAN (55301-874-01) | Antifungal Powder | ARMY & AIR FORCE EXCHANGE SERVICE | 2012-01-03 |
| 55505-0234-81 | 130 g in 1 CAN (55505-234-81) | Fungi Nail Everyday Antifungal Powder | Kramer Laboratories | 2025-01-01 |
| 58593-0285-04 | 130 g in 1 CANISTER (58593-285-04) | Hongo Killer | Efficient Laboratories Inc | 2002-03-01 |
| 63868-0181-46 | 130 g in 1 CAN (63868-181-46) | Tolnafate | Chain Drug Marketing Association | 2017-12-19 |
| 63941-0540-46 | 130 g in 1 CAN (63941-540-46) | Tolnafate | VALU MERCHANDISERS, CO. | 2017-10-31 |
| 63941-0541-46 | 130 g in 1 CAN (63941-541-46) | Tolnafate | VALU MERCHANDISERS, CO | 2017-10-31 |
| 68016-0653-46 | 130 g in 1 CAN (68016-653-46) | Tolnafate | Chain Drug Consortium, LLC | 2017-10-31 |
| 68016-0663-46 | 130 g in 1 CAN (68016-663-46) | Tolnafate | Chain Drug Consortium, LLC | 2017-12-05 |
| 69842-0512-46 | 130 g in 1 CAN (69842-512-46) | Tolnafate | CVS Pharmacy | 2017-05-22 |
| 70000-0322-01 | 130 g in 1 CAN (70000-0322-1) | Tolnafate | LEADER/ Cardinal Health 110, Inc. | 2017-10-20 |
| 79481-0607-01 | 130 g in 1 CAN (79481-0607-1) | Tolnafate | Meijer Distribution Inc. | 2023-08-18 |
| 79481-0622-01 | 113 g in 1 CAN (79481-0622-1) | Foot Odor Control Powder | Meijer Distribution Inc | 2023-08-28 |
| 79481-0623-01 | 130 g in 1 CAN (79481-0623-1) | Tolnafate | Meijer Distribution Inc. | 2023-08-18 |
| 79903-0016-46 | 130 g in 1 CAN (79903-016-46) | Tolnafate | Wal-Mart Stores, Inc | 2021-03-01 |
| 81929-0001-01 | 1 CAN in 1 BOX (81929-001-01) / 130 g in 1 CAN | Derman Antifungal Powder Tolnaftate | Taisho Pharmaceutical California Inc. | 2022-05-01 |
| 82442-0402-01 | 113 g in 1 CAN (82442-402-01) | Tolnaftate | Target Corporation | 2025-06-02 |
| 83324-0234-46 | 130 g in 1 CAN (83324-234-46) | Tolnafate | Chain Drug Marketing Association | 2025-04-10 |
Observed labelers:
Bayer HealthCare LLC. (6) ·
Formulated Solutions, LLC (6) ·
Topco Associates LLC (3) ·
Blistex Inc (2) ·
Chain Drug Consortium, LLC (2) ·
Chain Drug Marketing Association (2)
· +21 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.